Literature DB >> 9700138

Subepithelial fibrosis and degradation of the bronchial extracellular matrix in cystic fibrosis.

I Durieu1, S Peyrol, D Gindre, G Bellon, D V Durand, Y Pacheco.   

Abstract

Cystic fibrosis is a genetic disease caused by mutations of the cystic fibrosis transmembrane conductance regulator gene. Chronic inflammation and proteolysis lead to progressive damage of the bronchial wall. Extracellular matrix determines the structural organization and the mechanical properties of lung airways. It was thus examined in nine patients with cystic fibrosis (six bronchial biopsies and three lobectomies) in order to assess its level of alteration. The submucosal changes in matrix protein distribution were analyzed by immunochemistry and electron microscopy: the subepithelial basal lamina was thinned; an acellular collagen fiber layer composed of interstitial collagens (types I and III) subtended by tenascin and devoid of elastin-associated microfibrils was deposited beneath the basal lamina; this dense fibrous deposit generally formed a thick layer and could extend into the bronchial wall; the bronchial elastic framework lost arborescent distribution and appeared slender, packed, or lacunar; ultrastructural observation gave evidence for elastic and collagenic fiber lysis. Proteolytic activity is probably the major cause of matrix degradation. Fibrosis appears as a repair process rather than as an active fibrogenesis. The reversibility of extracellular matrix alterations is an important challenge and various interventions such as anti-inflammatory treatments can be targeted to halt or reverse this degradation process.

Entities:  

Mesh:

Year:  1998        PMID: 9700138     DOI: 10.1164/ajrccm.158.2.9707126

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

Review 1.  Roles of apoptosis in airway epithelia.

Authors:  Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-26       Impact factor: 6.914

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Alveolar inflammation in cystic fibrosis.

Authors:  Martina Ulrich; Dieter Worlitzsch; Simona Viglio; Nanna Siegmann; Paolo Iadarola; Janis K Shute; Marianne Geiser; Gerald B Pier; Godehard Friedel; Mark L Barr; Antje Schuster; Keith C Meyer; Felix Ratjen; Thomas Bjarnsholt; Erich Gulbins; Gerd Döring
Journal:  J Cyst Fibros       Date:  2010-03-29       Impact factor: 5.482

4.  Fas and Fas ligand expression in cystic fibrosis airway epithelium.

Authors:  I Durieu; C Amsellem; C Paulin; M T Chambe; J Bienvenu; G Bellon; Y Pacheco
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

5.  Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease.

Authors:  Sara L Fossum; Michael J Mutolo; Antonio Tugores; Sujana Ghosh; Scott H Randell; Lisa C Jones; Shih-Hsing Leir; Ann Harris
Journal:  J Biol Chem       Date:  2017-05-01       Impact factor: 5.157

6.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

7.  Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease.

Authors:  Milene T Saavedra; Grant J Hughes; Linda A Sanders; Michelle Carr; David M Rodman; Christopher D Coldren; Mark W Geraci; Scott D Sagel; Frank J Accurso; James West; Jerry A Nick
Journal:  Am J Respir Crit Care Med       Date:  2008-08-21       Impact factor: 21.405

8.  Airway remodelling in children with cystic fibrosis.

Authors:  Tom N Hilliard; Nicolas Regamey; Janis K Shute; Andrew G Nicholson; Eric W F W Alton; Andrew Bush; Jane C Davies
Journal:  Thorax       Date:  2007-05-25       Impact factor: 9.139

9.  Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.

Authors:  G V Shmarina; A L Pukhalsky; S N Kokarovtseva; D A Pukhalskaya; E A Kalashnikova; N I Kapranov; N J Kashirskaja
Journal:  Mediators Inflamm       Date:  2001-04       Impact factor: 4.711

Review 10.  Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.

Authors:  Virginia De Rose; Kevin Molloy; Sophie Gohy; Charles Pilette; Catherine M Greene
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.